ACTALIVE BIOTHERAPEUTIC PRODUCTS
Live / Registered — Registered (as of 06 Jul 2021)
What this means for you
Registered since 06 Jul 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 06 Jul 2027, and its filing window is open now).
Record
- Serial number
- 88929809
- Registration number
- 6412637
- Mark type
- Stylized text
- Filed
- 22 May 2020
- Published for opposition
- 06 Oct 2020
- Registered
- 06 Jul 2021
- Next maintenance filing
- §8 declaration of use, due by 06 Jul 2027 (grace period to 06 Jan 2028)
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 040 — Treatment of materials: Manufacturing services for others in the field of pharmaceuticals, biopharmaceuticals, biotherapeutic products, health care products and medical products; treatment of materials, namely, pharmaceutical, biologic, and chemical products and their components used in the manufacture of pharmaceuticals, biotherapeutic products, and biopharmaceuticals; manufacture of pharmaceuticals, biotherapeutic products, and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticals, biopharmaceuticals, and biotherapeutic products; contract manufacturing of pharmaceuticals, biopharmaceuticals, and biotherapeutic products and reagents
- Class 042 — Scientific and technological services: Research and development of pharmaceutical products, biopharmaceutical products, biotherapeutic products, health care products and medical products; scientific and technological consulting services in the pharmaceutical industry, and research and design relating thereto; industrial analysis in the nature of product testing and research and industrial research in the field of pharmaceuticals, biopharmaceuticals, biotherapeutic products, health care products and medical products; pharmaceutical and biopharmaceutical drug development services; product development consultation; product research services, namely, providing analytical testing, biosafety testing, reporting and laboratory services for others; scientific and technical product development consulting and research services for the pharmaceutical industry; custom design and development of chemical reagents and biochemical assays
Owner
- Arranta Bio Holdings, LLC, Watertown, MA, US
- Arranta Bio Holdings, LLC, Watertown, MA, US
- Arranta Bio Holdings, LLC, Watertown, MA, US
Prosecution history
- 06 Jul 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Jul 2021 — REGISTERED-PRINCIPAL REGISTER
- 03 Jun 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Jun 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 May 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 05 May 2021 — USE AMENDMENT FILED
- 15 May 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 May 2021 — TEAS STATEMENT OF USE RECEIVED
- 01 Dec 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Nov 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Nov 2020 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 19 Nov 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 Nov 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Oct 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Oct 2020 — PUBLISHED FOR OPPOSITION